Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Wednesday, 6 November 2019 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended on 30 September 2019.
The above information is a part of company’s filings submitted to BSE.